Johnson & Johnson (JNJ) PT Raised to $140 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
PlacementTracker Publishes Q1 2019 PIPE and Private Placement Markets League Tables
April 16, 2019 8:38 AM EDTNEW YORK, April 16, 2019 /PRNewswire/ --Â PlacementTracker, the leading source for data and analysis to institutions in the PIPE and Private Placement markets, today announced the most active investment banks, investors, and law firms in the U.S. PIPE and Private Placement markets for Q1 2019.
A total of $5.4 billion was raised in 235 transactions throughout Q1 of 2019. Of this amount, 1 transaction totaling $25 million has been announced but not yet closed as of 04/15/2019. Â Deal volume increased... More
Johnson & Johnson Reports 2019 First-Quarter Results:
April 16, 2019 6:40 AM EDTNEW BRUNSWICK, N.J., April 16, 2019 /PRNewswire/ --Â Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2019. "Our strong first-quarter results reflect continued underlying operational sales and adjusted EPS growth," said Alex Gorsky, Chairman and Chief Executive Officer. "At the same time, we remain focused on investing in innovative technologies and platforms that will make a meaningful difference in the lives of patients around the world. I am proud of our global colleagues' collective efforts to deliver on our long-term goals and our ability to create value for all of our stakeholders."
OVERALL... More
